BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liang JJ, Feng WJ, Li R, Xu RT, Liang YL. Analysis of the value and safety of thyroid-stimulating hormone in the clinical efficacy of patients with thyroid cancer. World J Clin Cases 2023; 11(5): 1058-1067 [PMID: 36874431 DOI: 10.12998/wjcc.v11.i5.1058]
URL: https://www.wjgnet.com/2307-8960/full/v11/i5/1058.htm
Number Citing Articles
1
L. ZHU, B-C. AHN. Natural Killer Cell-Derived Exosome Mimetics as Natural Nanocarriers for In Vitro Delivery of Chemotherapeutics to Thyroid Cancer CellsExperimental Oncology 2025; 46(4): 358 doi: 10.15407/exp-oncology.2024.04.358
2
Mei Guo, Yuqi Sun, Yuyao Wei, Jianxin Xu, Chun Zhang. Advances in targeted therapy and biomarker research in thyroid cancerFrontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1372553